Prelude Therapeutics Inc
NASDAQ:PRLD

Watchlist Manager
Prelude Therapeutics Inc Logo
Prelude Therapeutics Inc
NASDAQ:PRLD
Watchlist
Price: 1.46 USD -5.19% Market Closed
Market Cap: 91.8m USD

Wall Street
Price Targets

PRLD Price Targets Summary
Prelude Therapeutics Inc

Wall Street analysts forecast PRLD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRLD is 4.08 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

Lowest
Price Target
3.03 USD
108% Upside
Average
Price Target
4.08 USD
179% Upside
Highest
Price Target
5.25 USD
260% Upside
Prelude Therapeutics Inc Competitors:
Price Targets
DSGN
Design Therapeutics Inc
13% Downside
6160
Beigene Ltd
33% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
18% Upside
BIOCON
Biocon Ltd
12% Upside
CRNX
Crinetics Pharmaceuticals Inc
75% Upside
688105
Nanjing Vazyme Biotech Co Ltd
32% Upside
068270
Celltrion Inc
21% Upside
TECX
AVROBIO Inc
308% Upside

Revenue
Forecast

Revenue Estimate
Prelude Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prelude Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Prelude Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRLD's stock price target?
Price Target
4.08 USD

According to Wall Street analysts, the average 1-year price target for PRLD is 4.08 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

Back to Top